This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease.
The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease.
This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested.
It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease.
Recenzii
Nicio recenzie găsită.